About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

U.S. Home Infusion Therapy Market

U.S. Home Infusion Therapy Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

U.S. Home Infusion Therapy Market by Product (Devices, Drugs, Services), by Indication (Enteral Nutrition, Anti-Infective, Chemotherapy, Hydration Therapy, Total Parenteral Nutrition, Immunoglobulins, Others), by North America (Canada, United States, Mexico) Forecast 2026-2034

Jun 19 2025

Base Year: 2025

80 Pages

U.S. Home Infusion Therapy Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Key Insights

The size of the U.S. Home Infusion Therapy Market was valued at USD 17.26 USD billion in 2023 and is projected to reach USD 30.36 USD billion by 2032, with an expected CAGR of 8.4% during the forecast period. This growth is attributed to a confluence of factors, including the increasing prevalence of chronic diseases, the growing geriatric population, technological advancements in infusion devices and therapies, and the expansion of home healthcare services. Home Infusion Therapy (HIT) is a type of medical treatment that involves the administration of intravenous (IV) or subcutaneous medications to a patient in their home, rather than in a hospital or clinical setting. This therapy is typically used for patients who require long-term medication administration but do not need to stay in a hospital. It allows patients to receive care in the comfort of their own home while still receiving necessary treatments such as antibiotics, chemotherapy, pain management, and nutritional support.

U.S. Home Infusion Therapy Market Trends

The U.S. Home Infusion Therapy Market is witnessing multiple trends shaping its growth trajectory:

U.S. Home Infusion Therapy Market Market Size and Forecast (2024-2030) — U.S. Home Infusion Therapy Market Company Market Share

Driving Forces: What's Propelling the U.S. Home Infusion Therapy Market

The U.S. home infusion therapy market is experiencing robust growth, driven by a confluence of factors. These key drivers are reshaping the healthcare landscape and increasing the demand for convenient and effective at-home treatments.

Rising Preference for Home-Based Care: Patients are increasingly prioritizing comfort, convenience, and improved quality of life. Home infusion therapy allows patients to receive critical treatments in familiar surroundings, reducing stress and promoting faster recovery. This shift in patient preference is a major catalyst for market expansion.
Government Initiatives & Reimbursement Policies: Government support, including favorable reimbursement policies under Medicare Part B and other insurance programs, has significantly improved access to home infusion therapy. These initiatives are making the treatment more affordable and accessible to a wider patient population.
Cost-Effectiveness and Improved Resource Utilization: Compared to hospital-based treatments, home infusion therapy often presents a more cost-effective solution. By reducing the need for hospitalizations, readmissions, and associated costs, it offers significant value to both patients and the healthcare system. This cost efficiency further strengthens the market's growth trajectory.
Technological Advancements: Innovations in infusion technologies, such as wearable pumps, smart infusion systems, and remote monitoring capabilities, are enhancing patient safety, comfort, and treatment efficacy. These advancements are not only improving patient outcomes but also driving market expansion.

Challenges and Restraints in U.S. Home Infusion Therapy Market

The U.S. Home Infusion Therapy Market also encounters challenges and restraints:

Skilled Workforce Shortage: The demand for qualified healthcare professionals trained in home infusion therapy is outpacing supply, which poses a challenge to the industry's growth.
Reimbursement Issues: Reimbursement policies for home infusion therapy can vary widely across payers, leading to financial uncertainties for providers.
Patient Safety Concerns: Ensuring patient safety during home infusion therapy requires stringent protocols and monitoring, which can be a challenge.

Key Region or Country & Segment to Dominate the Market

Dominating Region or Country: The United States remains the dominant market for home infusion therapy, driven by its large and aging population, high prevalence of chronic diseases requiring infusion treatments, and a robust healthcare infrastructure that supports home healthcare services.

Dominating Segment: The drugs segment, encompassing a wide range of medications administered via infusion (including antibiotics, chemotherapy agents, and immunoglobulins), continues to hold a substantial market share due to the significant and growing demand for these specialized therapies within the home healthcare setting. This is further fueled by the increasing prevalence of chronic conditions requiring long-term infusion treatments.

Growth Catalysts in U.S. Home Infusion Therapy Industry

The U.S. Home Infusion Therapy Industry is poised for further growth due to several catalysts:

Rising Awareness: The increasing awareness of the benefits of home infusion therapy, such as improved patient outcomes, reduced costs, and greater convenience, is driving demand.
Advancements in Telehealth: Telehealth technologies are enabling remote monitoring of patients receiving home infusion therapy, improving patient safety and convenience.
Expansion of Telepharmacy: Telepharmacy services allow patients to receive medications and supplies directly to their homes, enhancing accessibility and reducing travel costs.

Market Segmentation: U.S. Home Infusion Therapy Analysis

Product

Devices
Drugs
Services

Indication

Enteral nutrition
Anti-infective
Chemotherapy
Hydration therapy
Total parenteral nutrition
Immunoglobulin
Others

Application

Oncology
Infectious diseases
Gastroenterology
Neurology
Others

Leading Players in the U.S. Home Infusion Therapy Market

Significant Developments in U.S. Home Infusion Therapy Sector

The U.S. home infusion therapy sector is a dynamic landscape characterized by significant ongoing developments. Recent key developments include:

Strategic Acquisitions and Mergers: Consolidation within the industry, such as the acquisition of BioScrip, Inc. by Envision Healthcare Corporation, reflects the growing importance and strategic value of home infusion services. These mergers and acquisitions expand service reach and capabilities.
Technological Innovation: The continuous development of innovative infusion technologies, like wearable infusion pumps and smart infusion systems, is improving patient experience and outcomes. These advancements enhance convenience, safety, and treatment adherence.
Expansion of Telepharmacy Services: The integration of telepharmacy services is enhancing access to medication management and support for patients receiving home infusion therapy. This provides enhanced convenience and oversight for patients.
Focus on Value-Based Care: The industry is increasingly shifting towards value-based care models, prioritizing improved patient outcomes and cost-effectiveness. This necessitates a focus on data-driven decision-making and efficient care coordination.

Regional Insight

While the U.S. currently holds the largest market share for home infusion therapy, growth potential exists globally. Emerging economies, such as India and China, are projected to experience significant market expansion driven by rising healthcare spending, increasing prevalence of chronic diseases, and improvements in healthcare infrastructure.

U.S. Home Infusion Therapy Market Market Share by Region - Global Geographic Distribution — U.S. Home Infusion Therapy Market Regional Market Share

DROCT

SWOT analysis, Porter's Five Forces, PESTEL analysis, and market share analysis are used to analyze the U.S. Home Infusion Therapy Market.

Pricing Analysis

Pricing in the U.S. Home Infusion Therapy Market varies depending on the type of therapy, drugs used, and provider. Home infusion therapy can be more cost-effective than hospital-based treatment, as it reduces the need for hospitalizations and readmissions.

Import And Export Analysis

The U.S. imports infusion pumps and other devices used in home infusion therapy from countries such as China, Germany, and Japan. The U.S. exports home infusion therapy products to countries with developing healthcare systems, such as those in Latin America and the Middle East.

Patent/Trademark Analysis

The U.S. Home Infusion Therapy Market is protected by various patents and trademarks. These patents cover innovative infusion technologies, drug formulations, and service delivery models.

Geographic Coverage of U.S. Home Infusion Therapy Market

Higher Coverage

Lower Coverage

No Coverage

U.S. Home Infusion Therapy Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 8.4% from 2020-2034
Segmentation	By Product Devices Drugs Services By Indication Enteral Nutrition Anti-Infective Chemotherapy Hydration Therapy Total Parenteral Nutrition Immunoglobulins Others By Geography North America Canada United States Mexico

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Increased Incidence of Cardiovascular and Other Chronic Disorders to Boost Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Safety Concerns Coupled with Resistance Among Patient Population to Limit Market Proliferation
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Home Infusion Therapy Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. Devices
  - 5.1.2. Drugs
  - 5.1.3. Services
- 5.2. Market Analysis, Insights and Forecast - by Indication
  - 5.2.1. Enteral Nutrition
  - 5.2.2. Anti-Infective
  - 5.2.3. Chemotherapy
  - 5.2.4. Hydration Therapy
  - 5.2.5. Total Parenteral Nutrition
  - 5.2.6. Immunoglobulins
  - 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1. North America
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Option Care Health Inc. (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Optum Inc. (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 CareCentrix Inc. (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 CVS Health (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 KabaFusion (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Promptcare Respiratory (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Baxter (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 InfuSystem Holdings Inc. (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Moog Inc. (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Option Care Health Inc. (U.S.)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)
    - 6.2.11 Optum Inc. (U.S.)
      6.2.11.1. Overview
      6.2.11.2. Products
      6.2.11.3. SWOT Analysis
      6.2.11.4. Recent Developments
      6.2.11.5. Financials (Based on Availability)
    - 6.2.12 CareCentrix Inc. (U.S.)
      6.2.12.1. Overview
      6.2.12.2. Products
      6.2.12.3. SWOT Analysis
      6.2.12.4. Recent Developments
      6.2.12.5. Financials (Based on Availability)
    - 6.2.13 CVS Health (U.S.)
      6.2.13.1. Overview
      6.2.13.2. Products
      6.2.13.3. SWOT Analysis
      6.2.13.4. Recent Developments
      6.2.13.5. Financials (Based on Availability)
    - 6.2.14 KabaFusion (U.S.)
      6.2.14.1. Overview
      6.2.14.2. Products
      6.2.14.3. SWOT Analysis
      6.2.14.4. Recent Developments
      6.2.14.5. Financials (Based on Availability)
    - 6.2.15 Promptcare Respiratory (U.S.)
      6.2.15.1. Overview
      6.2.15.2. Products
      6.2.15.3. SWOT Analysis
      6.2.15.4. Recent Developments
      6.2.15.5. Financials (Based on Availability)
    - 6.2.16 Baxter (U.S.)
      6.2.16.1. Overview
      6.2.16.2. Products
      6.2.16.3. SWOT Analysis
      6.2.16.4. Recent Developments
      6.2.16.5. Financials (Based on Availability)
    - 6.2.17 InfuSystem Holdings Inc. (U.S.)
      6.2.17.1. Overview
      6.2.17.2. Products
      6.2.17.3. SWOT Analysis
      6.2.17.4. Recent Developments
      6.2.17.5. Financials (Based on Availability)
    - 6.2.18 Moog Inc. (U.S.)
      6.2.18.1. Overview
      6.2.18.2. Products
      6.2.18.3. SWOT Analysis
      6.2.18.4. Recent Developments
      6.2.18.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Home Infusion Therapy Market Revenue Breakdown (USD billion, %) by Product 2025 & 2033
Figure 2: U.S. Home Infusion Therapy Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Product 2020 & 2033
Table 2: U.S. Home Infusion Therapy Market Volume Units Forecast, by Product 2020 & 2033
Table 3: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Indication 2020 & 2033
Table 4: U.S. Home Infusion Therapy Market Volume Units Forecast, by Indication 2020 & 2033
Table 5: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Region 2020 & 2033
Table 6: U.S. Home Infusion Therapy Market Volume Units Forecast, by Region 2020 & 2033
Table 7: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Product 2020 & 2033
Table 8: U.S. Home Infusion Therapy Market Volume Units Forecast, by Product 2020 & 2033
Table 9: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Indication 2020 & 2033
Table 10: U.S. Home Infusion Therapy Market Volume Units Forecast, by Indication 2020 & 2033
Table 11: U.S. Home Infusion Therapy Market Revenue USD billion Forecast, by Country 2020 & 2033
Table 12: U.S. Home Infusion Therapy Market Volume Units Forecast, by Country 2020 & 2033
Table 13: Canada U.S. Home Infusion Therapy Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 14: Canada U.S. Home Infusion Therapy Market Volume (Units) Forecast, by Application 2020 & 2033
Table 15: United States U.S. Home Infusion Therapy Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 16: United States U.S. Home Infusion Therapy Market Volume (Units) Forecast, by Application 2020 & 2033
Table 17: Mexico U.S. Home Infusion Therapy Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 18: Mexico U.S. Home Infusion Therapy Market Volume (Units) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Home Infusion Therapy Market?

The projected CAGR is approximately 8.4%.

2. Which companies are prominent players in the U.S. Home Infusion Therapy Market?

Key companies in the market include Option Care Health Inc. (U.S.), Optum Inc. (U.S.), CareCentrix Inc. (U.S.), CVS Health (U.S.), KabaFusion (U.S.), Promptcare Respiratory (U.S.), Baxter (U.S.), InfuSystem Holdings, Inc. (U.S.), Moog Inc. (U.S.), Option Care Health Inc. (U.S.), Optum Inc. (U.S.), CareCentrix Inc. (U.S.), CVS Health (U.S.), KabaFusion (U.S.), Promptcare Respiratory (U.S.), Baxter (U.S.), InfuSystem Holdings, Inc. (U.S.), Moog Inc. (U.S.).

3. What are the main segments of the U.S. Home Infusion Therapy Market?

The market segments include Product, Indication.

4. Can you provide details about the market size?

The market size is estimated to be USD 17.26 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Increased Incidence of Cardiovascular and Other Chronic Disorders to Boost Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Safety Concerns Coupled with Resistance Among Patient Population to Limit Market Proliferation.

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion and volume, measured in Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Home Infusion Therapy Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Home Infusion Therapy Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Home Infusion Therapy Market?

To stay informed about further developments, trends, and reports in the U.S. Home Infusion Therapy Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Home Infusion Therapy Market 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

Ambulatory Infusion Therapy Services Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Home Infusion Therapy Strategic Roadmap: Analysis and Forecasts 2025-2033

Home Infusion Services Strategic Insights: Analysis 2025 and Forecasts 2033

Home Infusion Therapy Services 2025-2033 Overview: Trends, Competitor Dynamics, and Opportunities

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report